PS PeptideSuppliers.org Finding the right peptide supplier for you
FOXO4-DRI reference image
Peptide guide

FOXO4-DRI Peptide Guide & Supplier Listing Notes

Cell-penetrating peptide designed to disrupt FOXO4-p53 interaction

Reported to clear senescent cells in mouse models; human safety/efficacy is unestablished.

Longevity and cellular research compounds Educational guide Supplier transparency
Educational disclaimer

Informational reference only

This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.

What it is

FOXO4-DRI at a glance

Cell-penetrating peptide designed to disrupt FOXO4-p53 interaction

Reported to clear senescent cells in mouse models; human safety/efficacy is unestablished.

Research context

Where current research places it

Cellular senescence, aging biology, apoptosis of senescent cells

Preclinical mouse/cell research

Research overview

Use the linked literature searches for current papers and trial records.

Current summary

What research has looked at

Reported to clear senescent cells in mouse models; human safety/efficacy is unestablished.

Evidence stage

How mature the research is

Preclinical mouse/cell research

Mechanism

How FOXO4-DRI is designed to target senescent cells

FOXO4-DRI is a cell-penetrating, D-retro-inverso peptide engineered to disrupt the interaction between FOXO4 and p53 inside senescent ("zombie") cells. In mouse studies, disrupting that interaction triggered apoptosis specifically in senescent cells while appearing to spare healthy ones, which is the core mechanism behind its senolytic research interest.

The "DRI" in its name refers to a peptide-engineering technique that reverses the amino acid sequence and substitutes D-amino acids, making the peptide more resistant to enzymatic breakdown and better able to cross cell membranes than a standard peptide of the same sequence.

Storage and handling notes

What clear supplier pages show

This category benefits from precise storage language, clear batch references, and product pages that separate documentation from headline copy.

  • Check whether the page clearly states the compound format being referenced.
  • Look for storage language that matches the label and any linked laboratory documentation.
  • Compare whether lot, batch, or COA references remain easy to access after the product details.
  • Note whether the page explains container, seal, or light-protection details in plain language.
Choosing a supplier page

What to compare when opening listings

The clearest FOXO4-DRI listings explain the technical label, keep the category context readable, and make documentation references easier to compare.

FOXO4-DRI pages are more credible when they rely on careful wording, category clarity, and laboratory documentation instead of futuristic or outcome-based language.

Linked supplier pages

Use these pages to compare naming, documentation access, and overall page clarity.

Supplier listing

Iron Peptides

This listing is useful for checking naming, documentation access, and overall page clarity.

10% off with code IRONMAN

Related peptides

Use related pages to compare nearby compounds and adjacent research categories.

Frequently asked questions

Quick answers to the main questions that come up on this page.

What is FOXO4-DRI?

Cell-penetrating peptide designed to disrupt FOXO4-p53 interaction

What research areas is it linked to?

Cellular senescence, aging biology, apoptosis of senescent cells

Preclinical mouse/cell research

What should stand out when comparing supplier pages?

The clearest FOXO4-DRI listings explain the technical label, keep the category context readable, and make documentation references easier to compare.

What does "DRI" mean in FOXO4-DRI?

DRI stands for D-retro-inverso, a peptide-engineering technique that reverses the amino acid sequence and uses D-amino acids to resist enzymatic breakdown and improve cell penetration.

Has FOXO4-DRI been tested in humans?

No. Published evidence is currently limited to mouse and cell-culture models, and human safety and efficacy remain unestablished.